a new ebola jab is being given to people living in the west africa countries most badly hit by the virus after human trials in unaffected countries proved successful
scientists hope that immunisation is possible with just one injection after ' highly promising results ' in the first 138 healthy adults who were vaccinated with various doses
the vaccine , developed in canada , is based on an animal virus called vesicular stomatitis virus ( vsv ) that is combined with a portion of the protein covering of the ebola virus